Accéder au contenu
Merck

HPLC Analysis of Recombinant Tumor Necrosis Factor Receptor-Fc Fusion Protein (rhTNFR-Fc) on Zenix® SEC-300 versus SRT® SEC-300, Effect of Particle Size on Resolution

HPLC Analysis of Recombinant Tumor Necrosis Factor Receptor-Fc Fusion Protein (rhTNFR-Fc) on Zenix® SEC-300 versus SRT® SEC-300, Effect of Particle Size on Resolution application for HPLC

Matériaux

Colonne analytique

Réf. du produit
Description
Tarif

Zenix® SEC-300 Gel Filtration Column, 3 μm

L × I.D. 30 cm × 7.8 mm, 3 μm particle size, stainless steel

SRT® SEC-300 Gel Filtration Column, 5 μm

L × I.D. 30 cm × 7.8 mm, 5 μm particle size, stainless steel

CONDITIONS

column

Zenix SEC-300, 30 cm x 7.8 mm I.D., 3 μm, 300 Å particles (Z777051)

column

SRT SEC-300, 30 cm x 7.8 mm I.D., 5 μm, 300 Å particles (Z777051) (Z777033)

mobile phase

150 mM sodium phosphate, pH 7.0

flow rate

1 mL/min

detector

UV, 214 nm

injection

20 μL

sample

Recombinant tumor necrosis factor receptor-Fc fusion protein (rhTNFR-Fc), including oligomers (440 kD and 360 kD), monomer (150 kD), and impurity (120 kD)

Description

Informations légales

SRT is a registered trademark of Sepax Technologies
Zenix is a registered trademark of Sepax Technologies